Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Relation between renal function and neointimal tissue characteristics after drug-eluting stent implantation: virtual histology-intravascular ultrasound analysis.

Hong YJ, Jeong MH, Choi YH, Park SY, Rhew SH, Kim SS, Jeong YW, Jeong HC, Cho JY, Jang SY, Lee KH, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC.

J Cardiol. 2014 Aug;64(2):98-104. doi: 10.1016/j.jjcc.2013.11.019. Epub 2014 Jan 8.

2.

In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents.

Wakabayashi K, Mintz G, Delhaye C, Choi YJ, Doh JH, Ben-Dor I, Gaglia M Jr, Pakala R, Suddath W, Satler L, Kent K, Pichard A, Weissman N, Waksman R.

J Invasive Cardiol. 2011 Jul;23(7):262-8.

3.

Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.

Kitabata H, Loh JP, Pendyala LK, Omar A, Ota H, Minha S, Magalhaes MA, Torguson R, Chen F, Satler LF, Pichard AD, Waksman R.

Cardiovasc Revasc Med. 2014 Apr;15(3):149-55. doi: 10.1016/j.carrev.2014.01.009. Epub 2014 Jan 20.

PMID:
24767313
4.
5.

Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.

Tsujita K, Takaoka N, Kaikita K, Hokimoto S, Horio E, Sato K, Mizobe M, Nakayama N, Kojima S, Tayama S, Sugiyama S, Nakamura S, Ogawa H.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):1068-74. doi: 10.1002/ccd.24907. Epub 2013 Mar 27.

PMID:
23460385
6.

Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Ando H, Amano T, Takashima H, Harada K, Kitagawa K, Suzuki A, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Uetani T, Kato M, Matsubara T, Kumagai S, Yoshikawa D, Isobe S, Ishii H, Murohara T.

Eur Heart J Cardiovasc Imaging. 2013 Oct;14(10):996-1001. doi: 10.1093/ehjci/jet003. Epub 2013 Jan 22.

PMID:
23341147
7.

Tissue characterization of in-stent neointima using intravascular ultrasound radiofrequency data analysis.

Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Lee CW, Han KH, Kim JJ, Park SW, Park SJ.

Am J Cardiol. 2010 Dec 1;106(11):1561-5. doi: 10.1016/j.amjcard.2010.07.031. Epub 2010 Oct 14.

PMID:
21094355
8.

Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.

Kwon SW, Kim BK, Kim TH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK.

Am Heart J. 2011 Feb;161(2):367-72. doi: 10.1016/j.ahj.2010.10.026.

9.

Renal dysfunction and atherosclerosis of the neointima following bare metal stent implantation.

Hayano S, Ishii H, Ichimiya S, Kanashiro M, Watanabe J, Suzuki S, Yoshikawa D, Maeda K, Matsubara T, Murohara T.

Am J Nephrol. 2013;38(1):58-65. doi: 10.1159/000353097. Epub 2013 Jul 2.

PMID:
23838572
10.

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.

Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Botker HE, Pedersen KE, Aaroe J, Christiansen EH, Vesterlund T, Hansen KN, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L.

EuroIntervention. 2011 Jul;7(3):323-31. doi: 10.4244/EIJV7I3A56.

11.

A newly formed and ruptured atheromatous plaque within neointima after drug-eluting stent implantation: 2-year follow-up intravascular ultrasound and optical coherence tomography studies.

Oh CM, Moon J, Yu HT, Jang JY, Kim JS, Ko YG, Choi D, Jang Y, Hong MK.

Yonsei Med J. 2011 Nov;52(6):1028-30. doi: 10.3349/ymj.2011.52.6.1028.

12.

In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.

Fukuhara K, Okura H, Kume T, Yamada R, Neishi Y, Uemura S.

J Cardiol. 2016 May;67(5):437-41. doi: 10.1016/j.jjcc.2015.07.002. Epub 2015 Aug 11.

13.

Impact of local endothelial shear stress on neointima and plaque following stent implantation in patients with ST-elevation myocardial infarction: A subgroup-analysis of the COMFORTABLE AMI-IBIS 4 trial.

Bourantas CV, Räber L, Zaugg S, Sakellarios A, Taniwaki M, Heg D, Moschovitis A, Radu M, Papafaklis MI, Kalatzis F, Naka KK, Fotiadis DI, Michalis LK, Serruys PW, Garcia Garcia HM, Windecker S.

Int J Cardiol. 2015;186:178-85. doi: 10.1016/j.ijcard.2015.03.160. Epub 2015 Mar 17.

PMID:
25828109
14.

Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.

Muraoka Y, Sonoda S, Kashiyama K, Kamezaki F, Tsuda Y, Araki M, Okazaki M, Otsuji Y.

Int J Cardiovasc Imaging. 2012 Oct;28(7):1635-41. doi: 10.1007/s10554-011-9997-9. Epub 2011 Dec 18.

PMID:
22179946
15.

Impact of polymer formulations on neointimal proliferation after zotarolimus-eluting stent with different polymers: insights from the RESOLUTE trial.

Waseda K, Ako J, Yamasaki M, Koizumi T, Sakurai R, Hongo Y, Koo BK, Ormiston J, Worthley SG, Whitbourn RJ, Walters DL, Meredith IT, Fitzgerald PJ, Honda Y.

Circ Cardiovasc Interv. 2011 Jun;4(3):248-55. doi: 10.1161/CIRCINTERVENTIONS.110.957548. Epub 2011 May 17.

16.

Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.

Kang SJ, Mintz GS, Akasaka T, Park DW, Lee JY, Kim WJ, Lee SW, Kim YH, Whan Lee C, Park SW, Park SJ.

Circulation. 2011 Jun 28;123(25):2954-63. doi: 10.1161/CIRCULATIONAHA.110.988436. Epub 2011 Jun 6.

17.

Detailed comparison of intra-stent conditions 12 months after implantation of everolimus-eluting stents in patients with ST-segment elevation myocardial infarction or stable angina pectoris.

Mizoguchi T, Sawada T, Shinke T, Yamada S, Okamoto H, Kim SS, Takarada A, Yasaka Y.

Int J Cardiol. 2014 Feb 1;171(2):224-30. doi: 10.1016/j.ijcard.2013.12.021. Epub 2013 Dec 21.

PMID:
24388538
18.

Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.

Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, Jang Y.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55. doi: 10.1016/j.jcmg.2012.01.024.

19.

Comparison of neointimal hyperplasia and peri-stent vascular remodeling after implantation of everolimus-eluting versus sirolimus-eluting stents: intravascular ultrasound results from the EXCELLENT study.

Ko YG, Shin DH, Kim JS, Kim BK, Choi D, Hong MK, Gwon HC, Ahn T, Chae IH, Yoon JH, Kim HS, Jang Y; EXCELLENT investigators.

Int J Cardiovasc Imaging. 2013 Aug;29(6):1229-36. doi: 10.1007/s10554-013-0199-5. Epub 2013 Mar 3.

PMID:
23456359
20.

Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B.

EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71.

Supplemental Content

Support Center